Rhizome AI

United States
Jersey City, New Jersey, United States, 07306

Company profile

Rhizome AI company profile

Rhizome AI is a generative AI-based regulatory intelligence platform for life sciences teams. It provides access to and analysis of data from global health authorities, including the FDA and EMA. The system integrates and updates datasets such as ClinicalTrials.gov, CTIS, and pre-approval therapeutics databases to deliver current regulatory information. It also organizes regulatory data into structured summaries with verified sources for decision-making in drug development and regulatory work.

Business identity

Contact email
[email protected]
Phone number
+1 571-201-0757
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
2024-10-01, Month

Headquarters

Postal code
07306
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$85,000
Last funding
Pre Seed / $85,000 / 2025-12-18
Last equity funding
Pre Seed / $85,000
Founders
1

Founders and investors

Founders

Chetan Mishra